| 12172983 |
EGFR inhibitors |
John Emmerson Campbell, Thomas A. Dineen, Natasja Brooijmans, Jason D. Brubaker, Meredith Suzanne Eno +6 more |
2024-12-24 |
| 12042495 |
MAP4K1 inhibitors |
Jason D. Brubaker, Michael J. Burke, Joshua Close, Thomas A. Dineen, Chandrasekhar V. Miduturu +1 more |
2024-07-23 |
| 11970498 |
CDK2 inhibitors |
Douglas Wilson, Neil Bifulco, Jr., Natasja Brooijmans, Philip Dean Ramsden, Richard Vargas +1 more |
2024-04-30 |
| 11932648 |
CDK2 inhibitors |
Douglas Wilson, Neil Bifulco, Jr., Natasja Brooijmans, Emanuele Perola, Philip Dean Ramsden +2 more |
2024-03-19 |
| 11827642 |
Compositions useful for treating disorders related to KIT |
Brian L. Hodous, Kevin J. Wilson, Douglas Wilson, Yulian Zhang |
2023-11-28 |
| 11718602 |
EGFR inhibitors |
Natasja Brooijmans, Jason D. Brubaker, John Emmerson Campbell, Christopher De Savi, Thomas A. Dineen +6 more |
2023-08-08 |
| 11634422 |
Inhibitors of activin receptor-like kinase |
Natasja Brooijmans, Jason D. Brubaker, Paul E. Fleming, Brian L. Hodous, Brett D. Williams +3 more |
2023-04-25 |
| 11534441 |
MAP4K1 inhibitors |
Jason D. Brubaker, Chandrasekhar V. Miduturu, Michael J. Burke, Thomas A. Dineen, Joshua Close +1 more |
2022-12-27 |
| 11447500 |
Thienopyridine derivatives and pharmaceutical composition comprising same |
Hyunho Lee, Chun Ho Park, Sun Chul HUR, Jai Hee Moon, Jae Sik Shin +5 more |
2022-09-20 |
| 11279688 |
Inhibitors of RET |
Jason D. Brubaker, Kevin J. Wilson, Douglas Wilson, Lucian V. DiPietro |
2022-03-22 |
| 11261497 |
PRKC fusions |
Nicolas Stransky |
2022-03-01 |
| 11236086 |
Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase |
Jason D. Brubaker, Paul E. Fleming, Brett D. Williams, Brian L. Hodous |
2022-02-01 |
| 11059827 |
Compounds and compositions useful for treating disorders related to NTRK |
Steven Mark Wenglowsky, Chandrasekhar V. Miduturu, Neil Bifulco, Jr. |
2021-07-13 |
| 11040979 |
Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR |
Brian L. Hodous, Kevin J. Wilson |
2021-06-22 |
| 10875930 |
PIK3C2G fusions |
Nicolas Stransky, Ethan G. Cerami, Christoph Lengauer |
2020-12-29 |
| 10774070 |
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors |
Natasja Brooijmans, Lucian V. DiPietro, Paul E. Fleming, Steven Mark Wenglowsky, Yulian Zhang |
2020-09-15 |
| 10752604 |
C-glucoside derivative containing fused phenyl ring or pharmaceutically acceptable salt thereof, process for preparing same, and pharmaceutical composition comprising same |
Joon Woo Nam, Jong Yup Kim, Kyung-Hoon Kim, Jung Mee Lee, Ji Yoon KIM +3 more |
2020-08-25 |
| 10696671 |
Imidazo[1,2-A]pyridine derivatives, methods for preparing the same and use thereof |
Jeongmin Kim, Hyunho Lee, Kwangwoo Chun, Chun Ho Park, Eunsung Jang +1 more |
2020-06-30 |
| 10584114 |
Inhibitors of RET |
Jason D. Brubaker, Kevin J. Wilson, Douglas Wilson, Lucian V. DiPietro |
2020-03-10 |
| 10378063 |
RAF1 fusions |
Nicolas Stransky |
2019-08-13 |
| 10370379 |
Compounds and compositions useful for treating disorders related to NTRK |
Steven Mark Wenglowsky, Chandrasekhar V. Miduturu, Neil Bifulco, Jr. |
2019-08-06 |
| 10370724 |
PRKC fusions |
Nicolas Stransky |
2019-08-06 |
| 10246750 |
Method for detection of a TECR:PKN1 or an ANXA4:PKN1 gene fusion |
Nicolas Stransky |
2019-04-02 |
| 10233186 |
Inhibitors of activin receptor-like kinase |
Natasja Brooijmans, Jason D. Brubaker, Mark Cronin, Paul E. Fleming, Brian L. Hodous +3 more |
2019-03-19 |
| 10202365 |
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors |
Natasja Brooijmans, Lucian V. DiPietro, Paul E. Fleming, Steven Mark Wenglowsky, Yulian Zhang |
2019-02-12 |